Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia.
about
Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fictionPharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UseReduced folate carrier and methylenetetrahydrofolate reductase gene polymorphisms: associations with clinical outcome in childhood acute lymphoblastic leukemiaStudy of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.A simple, bead-based approach for multi-SNP molecular haplotypingPolymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma.Methylenetetrahydrofolate reductase C677T and overall survival in pediatric acute lymphoblastic leukemia: a systematic review.Role of the MTHFR polymorphisms in cancer risk modification and treatment.Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis.PharmGKB summary: methotrexate pathway.Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?Germline genetic variation and treatment response on CCG-1891.Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.Pharmacogenetics of methotrexate.Priorities and standards in pharmacogenetic research.Associations between genetic variants in folate and drug metabolizing pathways and relapse risk in pediatric acute lymphoid leukemia on CCG-1952.Pharmacogenetics of folate-related drug targets in cancer treatment.Folate during antifolate chemotherapy: what we know... and do not know.Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology GroupGenetic variation and its role in malignancyComparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.Pharmacogenetics of acute lymphoblastic leukemia treatment response.Clinical pharmacogenetics in pediatric patients.Pharmacogenetics in acute lymphoblastic leukemia.Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies.Pharmacogenomics of pediatric acute lymphoblastic leukemia.Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis.A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia.Cancer pharmacogenomics in children: research initiatives and progress to date.Epigenetics: a new link between nutrition and cancer.Antileukemic drug effects in childhood acute lymphoblastic leukemia.Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.Pharmacogenetics of childhood acute lymphoblastic leukemia.Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention.Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.Gene polymorphisms in the folate metabolism and their association with MTX-related adverse events in the treatment of ALL.
P2860
Q27023839-D8849748-402B-499C-B921-0C3049249B92Q28068930-37CCC638-C6E2-4503-A640-F03F61AB630FQ28240130-7285852C-6B75-4BEE-A459-CC125879A3F1Q33395660-4B29FF4A-C2B6-442D-A61F-F7D2D781C89BQ33398162-2C8AC782-61D7-4FEA-A23F-5C2B594A10A8Q33754849-0346A518-E242-43AF-9F0D-DC2522656EC2Q33831942-CD059C5A-0075-4315-B58A-925EBD788F66Q34336668-6DFC2A2D-3BAD-4370-B187-F20473FB7A8BQ34658549-652CF860-CE40-48FB-9ED2-369E9F72FB15Q34934593-98DE8069-1294-4D59-8103-9D67FC15A092Q35115680-43A66042-FFC1-40BD-A3B1-7AF89E0B6385Q35135954-BD7EF25B-9F55-41CC-863A-944C009734DCQ35190653-C6A9CD3E-A2DF-493E-88A3-D24A2FAD3381Q35772582-46881BCB-AB74-4D01-9183-2656E94897A3Q35911142-D2A7808A-AB96-4C10-9362-A7F8D9F3AC07Q36180606-EA219AF1-DCA0-4DA9-A0A2-81856B2B3B1CQ36209626-7A22F6B4-42B5-4298-990D-C943E9106C71Q36278007-AEEE0E48-039D-4548-8080-A83312743D50Q36278412-32997E29-17F9-43FB-ADC3-A3515BE618E0Q36402208-5366788F-6CED-4ADC-B6E5-4DDE86EF887AQ36491833-7ABB0176-3B45-41D2-B182-213872F32A35Q36735686-9245998C-DA54-4ABD-B931-3A00F8E29BA8Q36940496-92DB0482-9564-46FF-868E-B41973B2B196Q36968156-2D330989-ED9F-4F39-8F0A-BD89F70A0FD6Q36989836-75DBAEBE-2016-4E94-9752-23DF5528ADFAQ37150913-000AA136-6F36-47BC-B2FB-FC886E20B00DQ37369929-86F5BA27-5DF2-41E1-BBCC-0CA38D53F058Q37413286-18A42C02-386D-4E5F-BB0A-165A3A147915Q37739432-087C9629-1A91-4B6B-A676-9F40E98F494CQ37808658-CE9352EA-8C98-40EA-B53F-B0454FF69A52Q37967954-AC3A0DC6-E60A-4A3B-96C7-81EB33A8180BQ38054428-440F12F2-7001-4C8E-B958-6C63B5402BA9Q38093137-84A749B5-FE7A-4CB7-B10A-45A984042979Q38126096-D04E4C14-33CA-44B1-A3AE-B791A5402A1AQ38178315-B1D2F8CB-B8BD-45DB-8363-B67954BA6B8CQ38199738-290DADCD-81D1-485A-9E31-AA460B9850A6Q38243175-DAE6001F-EA81-4E8A-88F4-F4E17987DE29Q38264774-6A78CE62-9ADB-4B60-906F-BD9358397CE9Q38416696-30A6A37D-85CA-49B9-B0C1-438E0DF29A2AQ38506522-EC548CDE-C60E-4579-9977-93D9376C0903
P2860
Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Role of polymorphisms in MTHFR ...... acute lymphoblastic leukemia.
@en
Role of polymorphisms in MTHFR ...... acute lymphoblastic leukemia.
@nl
type
label
Role of polymorphisms in MTHFR ...... acute lymphoblastic leukemia.
@en
Role of polymorphisms in MTHFR ...... acute lymphoblastic leukemia.
@nl
prefLabel
Role of polymorphisms in MTHFR ...... acute lymphoblastic leukemia.
@en
Role of polymorphisms in MTHFR ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1476
Role of polymorphisms in MTHFR ...... acute lymphoblastic leukemia.
@en
P2093
Chiasson S
Krajinovic M
Lemieux-Blanchard E
Moghrabi A
P2860
P2888
P356
10.1038/SJ.TPJ.6500224
P577
2004-01-01T00:00:00Z
P5875
P6179
1047767425